Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials

Ezzati, A., Davatzikos, C., Wolk, D. A., Hall, C. B., Habeck, C., & Lipton, R. B. (2022). Application of predictive models in boosting power of Alzheimer’s disease clinical trials: A post hoc analysis of phase 3 solanezumab trials. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 8(1). Portico. https://doi.org/10.1002/trc2.12223
Authors:
Ali Ezzati
Richard B. Lipton
Christos Davatzikos
David A. Wolk
Charles B. Hall
Christian Habeck
Affiliated Authors:
Christian Habeck
Columbia Affiliation:
Author Keywords:
alzheimer's disease
anti-amyloid monoclonal antibody
clinical trials
cognitive decline
machine learning
predictive analytics
elink
Publication Type:
Article
Unique ID:
10.1002/trc2.12223
PMID:
35310531
DOI:
10.1002/trc2.12223
Journal:
Alzheimer's and Dementia: Translational Research and Clinical Interventions
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: